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Abstract
Background The timing of embryo transfer (ET) after in
vitro fertilisation (IVF) remains controversial, and there are
no reliable guidelines available to prospectively identify
which patients would benefit from either day-3 or blasto-
cyst transfer. While blastocyst transfer is generally
favoured over day-3 transfers, very few IVF patients get
both in the same treatment cycle.
Case description We report on a 35.5-year-old female
with tubal factor infertility who underwent IVF, which
included transfer of a fresh day-3 embryo and a thawed
blastocyst frozen at day 6. Transfer occurred on two sep-
arate days (days 3 and 6) in a two-stage/dual catheter
fashion and resulted in a healthy term singleton livebirth.
Conclusions While combined day-3 and day-5 ET has
been available elsewhere for several years, this is the first
description of its successful application in Ireland and
confirms the effectiveness of coordinated two-stage trans-
fer in a single IVF treatment cycle.
Keywords Embryo transfer  Sequential  Two stage 
Blastocyst
Introduction
Embryo transfer (ET) is typically a single-step process
where all embryos destined for the uterus are placed by one
catheter. The timing of ET has long been controversial, but
as the human embryo normally arrives inside the uterine
compartment from the oviduct at the blastocyst stage,
many authorities have advocated this as a more natural and
physiologically preferred approach, superior to day 3 ET.
Moreover, when transferred at day 2 or 3, embryo devel-
opment is directed by maternal transcripts and stored
mRNA exclusively from the oocyte only, because the
embryonic genome remains latent at this time. Although
blastocyst transfer has distinct advantages over earlier
transfer protocols in in vitro fertilisation (IVF), intention-
ally culturing all embryos to blastocyst stage brings the risk
of cancelling the transfer should no embryos survive in
culture. To avoid this unfortunate outcome, a strategy of
consecutive (two stage) ET has been described [1, 2] where
the patient first has a day-3 transfer followed by a second
(blastocyst) transfer in the same cycle—usually 3 days
later. Although deployed elsewhere for several years, this
two-stage approach to ET for IVF patients has not been
reported in Ireland until now.
Case report
A 35.5-year-old non-smoking Caucasian G2 P1011 attended
for reproductive endocrinology consultation with a history
of bilateral tubal disease and unilateral oophorectomy. Two
years previously, the patient underwent IVF with a two-ET
(at day 3) which resulted in a healthy singleton term live-
birth; that treatment cycle also produced two embryos
which were cryopreserved at day 3 but did not survive
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thaw. She returned for a second fresh IVF cycle, but fol-
licular recruitment was poor and only one blastocyst was
available for transfer. Unfortunately, her transfer was
cancelled secondary to an intrauterine fluid collection
identified on transvaginal ultrasound. The single blastocyst
was frozen at day 6 with spontaneous resolution of the
endometrial fluid the following week.
The patient elected to begin a third fresh IVF cycle
2 months later, using a combined 600 IU/day FSH
(Puregon, Organon (Ireland) Ltd; Swords, Co. Dublin) ?
75 IU/day LH (Luveris, MSD Serono Ltd; Middlesex,
UK) ovulation induction protocol beginning on cycle day
2 without pituitary downregulation. Based on the endo-
crine status and follicular growth monitoring, we initiated
0.25 mg/day GnRH-antagonist (Orgalutran, Organon
(Ireland) Ltd; Swords, Co. Dublin) to suppress native LH
activity on day 9. Five oocytes were retrieved after a
12-day follicular recruitment phase, but only one advanced
to the 2pn stage following intracytoplasmic sperm injec-
tion. This single eight-cell embryo was transferred fresh
under transabdominal ultrasound guidance on day 3; the
remaining cryopreserved blastocyst was thawed next and
transferred on day 6. A positive pregnancy test was noted
12 days after the second-stage transfer and serial hCG
determinations were consistent with a normal pregnancy.
Early obstetrical ultrasound was performed on day 55 and
two distinct intrauterine implantation sites were noted.
These structures were asymmetric and the smaller sac
appeared empty. Follow-up sonograms confirmed the
regression of the smaller sac (see Fig. 1), and the larger
gestational sac included a foetal pole with a heart rate of
110 per min. Combined estradiol/progesterone support
was continued until the 12th week. An uncomplicated
obstetrical course followed, and a healthy male infant
(birth weight = 3,913 g) was delivered at 40 2/7 weeks’
gestation by Cesarian. Mother and baby were discharged
home in good condition after 5 days; both continue to
do well.
Discussion
Embryo transfer is the final and perhaps most critical step
in determining IVF outcome. Indeed, it has been estimated
that poor ET technique may account for many IVF fail-
ures—perhaps up to 30% of unsuccessful cycles [3]. It is
generally recognised that the skill of the clinician per-
forming ET is more important than catheter type or day of
transfer, although most ETs in IVF are done as one pro-
cedure where the uterine cavity receives all cultured
embryos from a single catheter at the same time. However,
recent work has suggested that a two-stage ET specifically
for patients with prior IVF failure can yield significantly
higher pregnancy rates compared with those having tradi-
tional one-step ET [4, 5]. Which ET procedure resulted in
the ongoing singleton pregnancy cannot be known with
certainty in our patient, but since allied research has sug-
gested that performing an endometrial biopsy prior to
actual transfer induces a favourable endometrial response
[6], we speculate that our patient’s viable pregnancy may
be a continuation of the blastocyst transfer.
In this report, we confirm the effectiveness of coordi-
nated two-stage transfer in a single cycle. Considerable
multi-centre data have shown that offering extended in
vitro culture and blastocyst transfer, whenever possible,
can provide significantly improved pregnancy rates com-
pared with traditional day-3 transfer [7, 8]. Day-3 transfer
can still be appropriate for some patients, but there are no
reliable guidelines available to prospectively identify
which patients would benefit from each treatment approach
[9]. Anticipating blastocyst transfer for every IVF patient is
inappropriate and risks cycle cancellation due to culture
failure, although we are unaware of any published data
identifying unsuccessful blastocyst culture as a specific
stressor causing patients to abandon IVF. Nevertheless,
patient education and counselling are a crucial component
of the pre-treatment programme for IVF. Although blas-
tocyst transfer is generally favoured at our institution, day
3 transfers are still performed when clinically indicated.
Very few IVF patients get both in the same treatment cycle,
however. The current case illustrates a plan tailored to meet
the disparate physiological needs of very different
embryos, and presents the first published report of a
delivery in Ireland after sequential ETs. Additional studies
are underway to evaluate this treatment approach for other
couples referred for prior IVF failure.
Fig. 1 Early pregnancy with regression of intrauterine implantation
site (a) and viable gestational sac (b) resulting from two-stage,
consecutive embryo transfer, as seen on transvaginal ultrasound at
8.5 weeks’ gestation
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